The Philadelphia Inquirer writes on the reported $2.2 billion Johnson & Johnson Risperdal settlement, the $2.3 billion Pfizer Geodon penalty, the $3 billion GlaxoSmithKline Avandia settlement, and the fact that “no human being, apparently, is going to be held responsible for substantial criminal activity by a corporation.”
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.